Location of Repository

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC).

By Mark A. Horsfield, Bruno Morgan, H. Krissel and Dirk Laurent


This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Annals of Oncology following peer review. The definitive publisher-authenticated version [Annals of Oncology, 2006, 17(Supplement 9), abstract PD732] is available online at: http://annonc.oxfordjournals.org/. This is an abstract of a paper presented at the 31st ESMO Congress 29 September - 3 October, 2006: Istanbul, Turkey. The published versions lists additional authors

Publisher: Oxford University Press
Year: 2006
OAI identifier: oai:lra.le.ac.uk:2381/1120

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.